Tamoxifen [orch, phsu]
cardiovascular risk factor [dsyn]
Normal [qlco]
postmenopausal [tmco]
Women [popg]
Interest [menp]
Anti-Estrogens [phsu]
Agent [chvf]
disease prevention [topp]
Women [popg]
Breast Cancer [neop]
Suggest [idcn]
synthetic estrogen [orch, phsu]
Tamoxifen [orch, phsu]
Cardiovascular disease [dsyn]
effects [qlco]
Agent [chvf]
cardiovascular risk factor [dsyn]
Health [idcn]
Women [popg]
Study [mnob]
Performed [ftcn]
randomized [resa]
placebo-controlled [resa]
Trial [resa]
effects [qlco]
Tamoxifen 20 MG [clnd]
Serum lipids NOS [lbpr]
Fibrinogen [aapp, bacs, phsu]
Body Composition [orga]
Normal [qlco]
postmenopausal [tmco]
Women [popg]
Tamoxifen [orch, phsu]
treatment [ftcn]
lowered [spco]
Levels [qlco]
serum cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
placebo [topp]
Levels [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Altered [ftcn]
Tamoxifen [orch, phsu]
Ratio [qnco]
Total Cholesterol [lbpr]
Cholesterol, HDL [bacs, lipd]
Decreased [qnco]
P NOS [aapp, imft]
placebo [topp]
Tamoxifen [orch, phsu]
Affect [menp]
Levels [qlco]
Triglycerides [bacs, lipd]
High density lipoprotein subfraction [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Apolipoprotein [aapp, bacs]
Glucose [bacs, carb, phsu]
Body Weight [orga]
Body Mass Index [diap]
Body Fat Distribution [fndg]
conclude [bodm, orch]
Tamoxifen [orch, phsu]
Levels [qlco]
Atherogenesis [patf]
Lipids [lipd]
Fibrinogen [aapp, bacs, phsu]
Normal [qlco]
postmenopausal [tmco]
Women [popg]
Suggest [idcn]
Anti-Estrogens [phsu]
Cardiovascular disease [dsyn]
postmenopausal [tmco]
Women [popg]
